|
|
| I FXIa / LegoChem Biosci (0 Trials) |
|
| I-0436650 / IRBM (0 Trials) |
|
| I-124 PGN650 / Avid Bioservices (0 Trials) |
|
| I-BET151 / GSK (0 Trials) |
|
| i-body enabled bi-specific CAR-T / Carina Biotech (0 Trials) |
|
| I-Drop / IMED AB (0 Trials) |
|
| I-Drop PM / IMED AB (0 Trials) |
|
| i-Gen (collagen) / Zenotech (0 Trials) |
|
| I-KEY (iron sucrose similar) / Serum Institute of India (0 Trials) |
|
| I-Lid 'n Lash Hygiene (hyaluronic acid) / IMED AB (0 Trials) |
|
| I.D.U.Senju (idoxuridine) / Senju (0 Trials) |
|
| I.V.-Globulin SN (human immune globulin intravenous) / GC Biopharma (0 Trials) |
|
| I004 (insulin aspart rapid-acting biosimilar) / Amphastar (0 Trials) |
|
| I025 / Shanghai Pharma (0 Trials) |
|
| I1907 / Boryung Group (0 Trials) |
|
| IA-1015 / ILAb (0 Trials) |
|
| IA-14069 / ILAb (0 Trials) |
|
| IA001 (tocilizumab biosimilar) / Liaoning Grand Nuokang Biopharma, Mabwell (Shanghai) Biosci (0 Trials) |
|
| IACS-010759 / UT MD Anderson Cancer Center (2 Trials) |
|
| iadademstat (ORY-1001) / Oryzon (10 Trials) |
|
| IAE0972 / SunHo BioPharma (0 Trials) |
|
| IAG933 / Novartis (0 Trials) |
|
| IAH0968 / SunHo BioPharma (0 Trials) |
|
| IAMA-6 / IAMA Therap (0 Trials) |
|
| ianalumab (VAY736) / Novartis (22 Trials) |
|
| IAP0971 / SunHo BioPharma (0 Trials) |
|
| IB-002A / ILiAD Biotechnologies (0 Trials) |
|
| IB-007 / ILiAD Biotechnologies (0 Trials) |
|
| IB-AD / InnoBioscience (0 Trials) |
|
| IB-DMD / InnoBioscience (0 Trials) |
|
| IB08C179 / Biomar Microbial Technologies (0 Trials) |
|
| IB1007 / Emergent Biosolutions (0 Trials) |
|
| IB1008 / Emergent Biosolutions (0 Trials) |
|
| ibandronate sodium hydrate / Generic mfg. (8 Trials) |
|
| IBAT Inhibitor / Ipsen (0 Trials) |
|
| IBC-Ab002 / ImmunoBrain Checkpoint (0 Trials) |
|
| IBC-VS01 / Orban Biotech (0 Trials) |
|
| IBC0966 / SunHo BioPharma (0 Trials) |
|
| IBCH 05 / Pharma Bio (0 Trials) |
|
| ibentatug (ZB131) / ZielBio (0 Trials) |
|
| iberdomide (CC-220) / BMS (34 Trials) |
|
| ibezapolstat (ACX-362E) / Acurx Pharma (0 Trials) |
|
| IBI-102 / Innovent Biologics (0 Trials) |
|
| IBI-104 / Innovent Biologics (0 Trials) |
|
| IBI-310 (ipilimumab biosimilar) / Innovent Biologics (0 Trials) |
|
| IBI-323 / Innovent Biologics (0 Trials) |
|
| IBI-324 / Innovent Biologics (0 Trials) |
|
| IBI-325 / Innovent Biologics (0 Trials) |
|
| IBI-333 / Innovent Biologics (0 Trials) |
|
| IBI-343 / Innovent Biologics (0 Trials) |
|
| IBI-345 / Innovent Biologics, Roche (0 Trials) |
|
| IBI-354 / Innovent Biologics (0 Trials) |
|
| IBI-363 / Innovent Biologics (0 Trials) |
|
| IBI-389 / Innovent Biologics (0 Trials) |
|
| IBI110 / Innovent Biologics (0 Trials) |
|
| IBI311 / Innovent Biologics (0 Trials) |
|
| IBI314 / Innovent Biologics (0 Trials) |
|
| IBI319 / Eli Lilly (0 Trials) |
|
| IBI321 / Innovent Biologics, Eli Lilly (0 Trials) |
|
| IBI327 / Innovent Biologics (0 Trials) |
|
| IBI346 / Innovent Biologics (0 Trials) |
|
| IBI360 / Innovent Biologics (0 Trials) |
|
| IBI38D9-L / Innovent Biologics (0 Trials) |
|
| IBIO-100 / iBio (0 Trials) |
|
| IBIO-200 / iBio, CC-Pharming, Infectious Disease Research Institute (0 Trials) |
|
| IBIO-201 / iBio (0 Trials) |
|
| IBIO123 / Immune Biosolutions (0 Trials) |
|
| iBioLaunch-produced recombinant C1 esterase inhibitor / iBio (0 Trials) |
|
| IBL-100s / Mysthera Therap (0 Trials) |
|
| IBL-202 / Inflection Biosci (0 Trials) |
|
| IBL-301 / Inflection Biosci (0 Trials) |
|
| iboctadekin (SB-485232) / GSK (0 Trials) |
|
| Ibodutant (MEN 15596) / Menarini (0 Trials) |
|
| ibogaine (DMX-1002) / atai Life Sci (0 Trials) |
|
| ibogaine (MC-808) / Mindcure (0 Trials) |
|
| IBR120 / University of California (0 Trials) |
|
| IBR2 / University of California (0 Trials) |
|
| IBR733 / Imbioray Bio (0 Trials) |
|
| IBR854 / Imbioray Bio (0 Trials) |
|
| IBR900 / Imbioray Bio (0 Trials) |
|
| Ibrance (palbociclib) / Pfizer (205 Trials) |
|
| iBRD4i / BeiGene (0 Trials) |
|
| ibrilatazar (ABTL0812) / Ability Pharma (0 Trials) |
|
| IBS70 / JADO Tech (0 Trials) |
|
| Ibsrela (tenapanor) / Ardelyx (6 Trials) |
|
| ibudilast/bumetanide (STP1) / STALICLA (0 Trials) |
|
| ibuprofen / Generic mfg. (122 Trials) |
|
| ibuprofen (OXP001) / Oxford Pharmascience (0 Trials) |
|
| ibuprofen (SST-0225) / Strategic Science & Technologies (0 Trials) |
|
| ibuprofen lozenges (V-0498) / Pierre Fabre (0 Trials) |
|
| ibuprofen lysine / Generic mfg. (1 Trials) |
|
| ibuprofen topical (TIB200) / Futura Medical (0 Trials) |
|
| ibuprofen-VALE (10% transdermal ibuprofen) / BioChemics (0 Trials) |
|
| ibuprofen/oxycodone / Generic mfg. (0 Trials) |
|
| ibuprofenamine (X-0002) / Techfields (2 Trials) |
|
| ibutilide / Generic mfg. (0 Trials) |
|
| ibuzatrelvir (PF-07817883) / Pfizer (0 Trials) |
|
| IC 100 / ZyVersa (0 Trials) |
|
| IC 200 / ZyVersa (0 Trials) |
|
| IC 300 / ZyVersa (0 Trials) |
|
| IC 41 / Valneva, Novartis (0 Trials) |
|
| IC 486051 / Eli Lilly (0 Trials) |
|
| IC 805 / Pharmaleads, IACTA Pharma (0 Trials) |
|
| IC-100 / Astellas (0 Trials) |
|
| IC-200 / Astellas (0 Trials) |
|
| IC-500 / Astellas (0 Trials) |
|
| IC-BEVS recombinant S protein coronavirus vaccine / Vabiotech (0 Trials) |
|
| IC800 / IACTA Pharma (0 Trials) |
|
| IC805 / IACTA Pharma (0 Trials) |
|
| IC87201 / Anagin (0 Trials) |
|
| iC9-CAR19 cells / Bellicum (0 Trials) |
|
| iC9-GD2-CAR-VZV-CTLs / Baylor College of Medicine (1 Trials) |
|
| iC9.GD2.CAR.IL-15 T-cells / UNC Lineberger Comprehensive Cancer Center (0 Trials) |
|
| ICA-1 / University of South Florida (0 Trials) |
|
| ICA-105665 / Pfizer (0 Trials) |
|
| ICA6150349 / i20 Therap (0 Trials) |
|
| icalcaprant (CVL-354) / AbbVie (0 Trials) |
|
| icanbelimod (CBP-307) / Suzhou Connect Biopharma (0 Trials) |
|
| icapamespib (PU-AD) / Samus Therap (0 Trials) |
|
| iCAR-ILC-N101 / National Cancer Center Hospital East (0 Trials) |
|
| ICAR19 CAR-T cells / Immune Cell Therapy (0 Trials) |
|
| icaritin (SNG-162) / Shenogen Pharma (4 Trials) |
|
| icaritin/pexastimogene devacirepvec (Pexa-Vec/icaritin) / Lee's Pharm (0 Trials) |
|
| iCasp9M28z T cell infusion / Memorial Sloan-Kettering Cancer Center, Bellicum (1 Trials) |
|
| iCaspase9-transduced T cells / Baylor College of Medicine (0 Trials) |
|
| ICE 1201 / Iroko (0 Trials) |
|
| ICE 1202 / Iroko (0 Trials) |
|
| ICE 1203 / Iroko (0 Trials) |
|
| ICE 1204 / Iroko (0 Trials) |
|
| ICE 1207 / Iroko (0 Trials) |
|
| ICE 1208 / Iroko (0 Trials) |
|
| ICE 1209 / Iroko (0 Trials) |
|
| ICE 1210 / Iroko (0 Trials) |
|
| ICE 1211 / Iroko (0 Trials) |
|
| icenticaftor (QBW251) / Novartis (4 Trials) |
|
| icerguastat (IFB-088) / InFlectis (0 Trials) |
|
| ICG-126 / iCell Gene Therap (0 Trials) |
|
| ICG-136 / iCell Gene Therap (0 Trials) |
|
| ICG-138/ICG-139 / iCell Gene Therap (0 Trials) |
|
| ICG-140 / iCell Gene Therap (0 Trials) |
|
| ICG-142 / iCell Gene Therap (0 Trials) |
|
| ICG122 / iCell Gene Therap (2 Trials) |
|
| ICG124 / iCell Gene Therap (1 Trials) |
|
| ICG132 / iCell Gene Therap, Guiqidan Biomedicine (0 Trials) |
|
| ICG134 / iCell Gene Therap (0 Trials) |
|
| ICG165 / iCell Gene Therap (0 Trials) |
|
| ICG180 / Guiqidan Biomedicine (0 Trials) |
|
| ICG181 / Guiqidan Biomedicine (0 Trials) |
|
| ICG186 / Guiqidan Biomedicine (0 Trials) |
|
| Ichorcumab (JNJ-64179375) / J&J (0 Trials) |
|
| iclaprim (MTF-100) / Motif Bio (0 Trials) |
|
| iclepertin (BI425809) / Boehringer Ingelheim (0 Trials) |
|
| Iclusig (ponatinib) / Takeda, Otsuka (40 Trials) |
|
| ICM-203 / Yonsei Technology Holdings (0 Trials) |
|
| ICM-302 / Yonsei Technology Holdings (0 Trials) |
|
| iCo-007 / Ionis (0 Trials) |
|
| icosabutate (NST-4016) / Abbott, NorthSea Therap (1 Trials) |
|
| icosapent (MND-2119) / Mochida, Amarin (0 Trials) |
|
| icosapent ethyl / Generic mfg. (6 Trials) |
|
| icosapent ethyl/ rosuvastatin (AMR 102) / Amarin (0 Trials) |
|
| ICOSL vIgD / Alpine Immune Sci (0 Trials) |
|
| icovamenib (BMF-219) / Biomea Fusion (0 Trials) |
|
| ICP-033 / InnoCare (0 Trials) |
|
| ICP-105 / InnoCare (0 Trials) |
|
| ICP-189 / InnoCare (0 Trials) |
|
| ICP-248 / InnoCare (0 Trials) |
|
| ICP-332 / InnoCare (0 Trials) |
|
| ICP-488 / InnoCare (0 Trials) |
|
| ICP-490 / InnoCare (0 Trials) |
|
| ICP-915 / InnoCare (0 Trials) |
|
| ICP-B03 / InnoCare (0 Trials) |
|
| ICP-B05 / InnoCare, Keymed Biosciences (0 Trials) |
|
| iCP-NI / Cellivery (0 Trials) |
|
| ICR62 / Roche (0 Trials) |
|
| icrucumab (IMC-18F1) / Eli Lilly (0 Trials) |
|
| ICT 1001 / Immune Cell Therapy (0 Trials) |
|
| ICT-107 / Targepeutics, EOM Pharma (0 Trials) |
|
| ICT-121 / EOM Pharma (0 Trials) |
|
| ICT-140 / EOM Pharma (0 Trials) |
|
| ICT01 / ImCheck Therap (0 Trials) |
|
| ICT03 / ImCheck Therap (0 Trials) |
|
| ICT04 / ImCheck Therap (0 Trials) |
|
| ICT04-CYP / Incanthera (0 Trials) |
|
| ICT05 / ImCheck Therap (0 Trials) |
|
| ICT06 / ImCheck Therap (0 Trials) |
|
| ICT07 / ImCheck Therap (0 Trials) |
|
| ICT08 / ImCheck Therap (0 Trials) |
|
| ICT091 / Innovative Cellular Therapeutics (0 Trials) |
|
| ICT21 / ImCheck Therap (0 Trials) |
|
| ICT23 / ImCheck Therap (0 Trials) |
|
| ICTCAR-TC / Innovative Cellular Therapeutics (0 Trials) |
|
| ICTCAR-TCR Hybrid / Innovative Cellular Therapeutics (0 Trials) |
|
| ICTCAR003 / Innovative Cellular Therapeutics (0 Trials) |
|
| ICTCAR014 / Innovative Cellular Therapeutics (0 Trials) |
|
| ICTCAR023 / Innovative Cellular Therapeutics (0 Trials) |
|
| ICTCAR046 / Innovative Cellular Therapeutics (0 Trials) |
|
| ICV 0019 / Hawkley Oil and Gas (0 Trials) |
|
| ICVB-1042 / IconOVir (0 Trials) |
|
| ID-085 / Idorsia (0 Trials) |
|
| ID-12005A / Ildong (0 Trials) |
|
|